首页> 外文期刊>Gastroenterology research and practice >The Feasibility and Histological Diagnostic Accuracy of Novel Menghini Needle (EUS Sonopsy CY?) for Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy of Solid Pancreatic Masses: A Prospective Crossover Study Comparing Standard Biopsy Needles
【24h】

The Feasibility and Histological Diagnostic Accuracy of Novel Menghini Needle (EUS Sonopsy CY?) for Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy of Solid Pancreatic Masses: A Prospective Crossover Study Comparing Standard Biopsy Needles

机译:用于内窥镜超声引导的固体胰腺质量的内窥镜超声波引导细针吸入活检的新型乳腺针(EUS SOOPOPSY CY的可行性和组织学诊断准确性

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Objectives. Recently, a 21G Menghini-type needle for EUS-guided fine-needle aspiration biopsy (EUS-FNAB) has been developed. The stylet of the EUS Sonopsy CY? remains inside the needle during aspiration. Therefore, it is expected to obtain higher-quality histological core specimens without crushing the material or blood contamination. The aim of this study is to evaluate the feasibility and diagnostic accuracy of EUS-FNAB of solid pancreatic masses with this new biopsy needle. Methods. A total of 30 patients with solid pancreatic masses who underwent EUS-FNAB with two different types of needles, EUS Sonopsy? and ProCore?, were included in a prospective, randomized, controlled, crossover study. All the pancreatic masses were punctured with the two needles and were randomized regarding the order of the needle to be used. The primary outcome was to compare the diagnostic accuracy and the rates of tissue acquisition of the two needles. Results. The tissue acquisition rate was not significantly different between the EUS Sonopsy CY? needle and the ProCore? needle (78.6% vs. 82.1%, P=1.00). The histological diagnostic accuracy was also similar between the two needles (73% vs. 80%, P=.63). There was also no difference regarding the accuracy of cytology alone and the combination of both histological and cytological assessments between the EUS Sonopsy CY? needle and the ProCore? needle (90% vs. 87%, P=1.00 and 90% vs. 90%, P=1.00, respectively). Conclusions. EUS Sonopsy CY? is a reliable device for EUS-FNAB of solid pancreatic masses.
机译:背景和目标。最近,已经开发出用于EUS引导的细针吸入活检(EUS-FNAB)的21G蒙氏型针。 EUS SOOPOPSY CY的Stylet?在抽吸期间留在针内。因此,预计将获得更高质量的组织学核心标本,而不会粉碎材料或血液污染。本研究的目的是评估固体胰腺肿块与这种新的活检针的可行性和诊断准确性。方法。共有30名患者的固体胰腺肿块,患有两种不同类型针的EUS-FUBAB,EUS超声波?和Procore?,包含在预期,随机,受控,交叉研究中。所有胰质量均用两根针刺,并随机关于要使用针的顺序。主要结果是比较诊断准确性和组织采集的速率。结果。 EUS SOOPOPSY CY之间的组织采集率没有显着差异吗?针和procore?针(78.6%vs.82.1%,p = 1.00)。两根针之间的组织学诊断精度也相似(73%对80%,p = .63)。单独的细胞学准确性也没有差异,并且EUS超声波CY之间的组织学和细胞学评估的组合组合?针和procore?针(90%vs.87%,P = 1.00和90%与90%,P = 1.00分别)。结论。 eus sonopsy cy?是固体胰腺肿块EUS-FNAB的可靠装置。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号